Lupin Ltd has received final approval for its sodium sulfate, potassium sulfate, and magnesium sulfate oral solution, 17.5 g/3.13 g/1.6 g per 6 ounces, from the US Food and Drug Administration (FDA) to market a generic version of Braintree Laboratories’ Suprep bowel prep kit.
According to Lupin, it is eligible for 180 days of generic drug exclusivity for the approved product, which indicated for cleansing of the colon in preparation for colonoscopy in adults. As per IMS (MAT December 2016), Suprep bowel prep kit had US sales of $ 207.2 million.
Meanwhile, Lupin Limited has also received final approval for its oxycodone